Tobias Rosenkranz
Tobias Rosenkranz is the head of biomolecule formulation for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Articles
Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Can Araman;Moritz Beck-Broichsitter;Nelli Erwin ;Supriyadi Hafiz ;Adela Kasselkus ;Thomas Kipping ;David Luedeker ;Aditi Mehta ;Lena Mueller;Sara S. Nogueira;Tobias Rosenkranz;Eleni Samaridou;Johanna Simon
October 7th 2022Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: October 28th 2024 | Updated: November 23rd 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 6th 2024 | Updated: November 23rd 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 23rd 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 23rd 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
